No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy

Morten Krogh Jensen

doi:10.1200/JCO.2012.47.9238

No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy

Morten Krogh Jensen

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Vol/bind	31
Udgave nummer	13
Sider (fra-til)	1700
Antal sider	1
ISSN	0732-183X
DOI	https://doi.org/10.1200/JCO.2012.47.9238
Status	Udgivet - 1 maj 2013

Adgang til dokumentet

10.1200/JCO.2012.47.9238

Citationsformater

No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy. / Jensen, Morten Krogh.
I: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Bind 31, Nr. 13, 01.05.2013, s. 1700.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{4e2cd5697c8e49b884c3ec007de1de56,

title = "No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy",

keywords = "Aminoglycosides, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Leukemia, Myeloid, Acute, Male, Myelodysplastic Syndromes",

author = "Jensen, {Morten Krogh}",

year = "2013",

month = may,

day = "1",

doi = "10.1200/JCO.2012.47.9238",

language = "English",

volume = "31",

pages = "1700",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "13",

}

TY - JOUR

T1 - No evidence of survival benefit with addition of gemtuzumab ozogamicin to standard medical research council induction chemotherapy

AU - Jensen, Morten Krogh

PY - 2013/5/1

Y1 - 2013/5/1

KW - Aminoglycosides

KW - Antibodies, Monoclonal, Humanized

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Female

KW - Humans

KW - Leukemia, Myeloid, Acute

KW - Male

KW - Myelodysplastic Syndromes

U2 - 10.1200/JCO.2012.47.9238

DO - 10.1200/JCO.2012.47.9238

M3 - Journal article

C2 - 23530103

SN - 0732-183X

VL - 31

SP - 1700

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 13

ER -